Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aseem Pandey

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Vaccine|February 21, 2021
Safety and immunogenicity of high doses of quadrivalent influenza vaccine in children 6 months through <18 years of age: A randomized controlled phase II dose-finding trialLee-Jah Chang, Evan J Anderson, Robert Jeanfreau, et al.
Vaccine|March 11, 2023
Superior immunogenicity of high-dose quadrivalent inactivated influenza vaccine versus Standard-Dose vaccine in Japanese Adults ≥ 60 years of age: Results from a phase III, randomized clinical trialLeilani Sanchez, Takahiro Nakama, Hideaki Nagai, et al.
Viral Immunology|July 23, 2016
Rapamycin Does Not Impede Survival or Induction of Antibody Responses to Primary and Heterosubtypic Influenza Infections in MiceJustine S Liepkalns, Aseem Pandey, Amelia R Hofstetter, et al.
The Journal of Infectious Diseases|May 9, 2008
A broadly protective vaccine against globally dispersed clade 1 and clade 2 H5N1 influenza virusesMary A Hoelscher, Neetu Singh, Sanjay Garg, et al.
The Lancet. Respiratory Medicine|February 3, 2022
Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label studyRuvim Izikson, Daniel Brune, Jean-Sébastien Bolduc, et al.
The Pediatric Infectious Disease Journal|August 20, 2025
Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and InfantsSylvie Pichon, Gary M Ullery, Luis Cousin, et al.
Frontiers in Cellular and Infection Microbiology|May 8, 2018
Activation of Host IRE1α-Dependent Signaling Axis Contributes the Intracellular Parasitism of <i>Brucella melitensis</i>Aseem Pandey, Furong Lin, Ana L Cabello, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 3, 2012
Rapid differentiation of monocytes into type I IFN-producing myeloid dendritic cells as an antiviral strategy against influenza virus infectionWeiping Cao, Andrew K Taylor, Renata E Biber, et al.
Iscience|March 15, 2021
Interactions between fungal hyaluronic acid and host CD44 promote internalization by recruiting host autophagy proteins to forming phagosomesShengli Ding, Jing Yang, Xuehuan Feng, et al.
Elife|May 19, 2022
<i>Brucella</i> activates the host RIDD pathway to subvert BLOS1-directed immune defenseKelsey Michelle Wells, Kai He, Aseem Pandey, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Vaccine|February 21, 2021
Safety and immunogenicity of high doses of quadrivalent influenza vaccine in children 6 months through <18 years of age: A randomized controlled phase II dose-finding trialLee-Jah Chang, Evan J Anderson, Robert Jeanfreau, et al.
Vaccine|March 11, 2023
Superior immunogenicity of high-dose quadrivalent inactivated influenza vaccine versus Standard-Dose vaccine in Japanese Adults ≥ 60 years of age: Results from a phase III, randomized clinical trialLeilani Sanchez, Takahiro Nakama, Hideaki Nagai, et al.
Viral Immunology|July 23, 2016
Rapamycin Does Not Impede Survival or Induction of Antibody Responses to Primary and Heterosubtypic Influenza Infections in MiceJustine S Liepkalns, Aseem Pandey, Amelia R Hofstetter, et al.
The Journal of Infectious Diseases|May 9, 2008
A broadly protective vaccine against globally dispersed clade 1 and clade 2 H5N1 influenza virusesMary A Hoelscher, Neetu Singh, Sanjay Garg, et al.
The Lancet. Respiratory Medicine|February 3, 2022
Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label studyRuvim Izikson, Daniel Brune, Jean-Sébastien Bolduc, et al.
The Pediatric Infectious Disease Journal|August 20, 2025
Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and InfantsSylvie Pichon, Gary M Ullery, Luis Cousin, et al.
Frontiers in Cellular and Infection Microbiology|May 8, 2018
Activation of Host IRE1α-Dependent Signaling Axis Contributes the Intracellular Parasitism of <i>Brucella melitensis</i>Aseem Pandey, Furong Lin, Ana L Cabello, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 3, 2012
Rapid differentiation of monocytes into type I IFN-producing myeloid dendritic cells as an antiviral strategy against influenza virus infectionWeiping Cao, Andrew K Taylor, Renata E Biber, et al.
Iscience|March 15, 2021
Interactions between fungal hyaluronic acid and host CD44 promote internalization by recruiting host autophagy proteins to forming phagosomesShengli Ding, Jing Yang, Xuehuan Feng, et al.
Elife|May 19, 2022
<i>Brucella</i> activates the host RIDD pathway to subvert BLOS1-directed immune defenseKelsey Michelle Wells, Kai He, Aseem Pandey, et al.
Pageof 3